Our observation of significantly higher levels of stromal p16 expression in malignant ovarian lesions suggests that p16 may be involved in tumor cell growth and invasion in the tumor microenvironment through its overexpression in stromal cells. This evidence concerns the gene CDKN2A and neoplasm.